F13.159
Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.159 pertains to a specific mental health condition involving the misuse of sedatives, hypnotics, or anxiolytics that results in a psychotic disorder. This condition signifies a complex interaction between substance abuse and mental health, requiring comprehensive awareness and management. It is classified as a substance-related disorder coupled with a psychotic episode, which can significantly impact a person’s perception, thought processes, and behavior.
Causes & Symptoms
Clinical Causes: Repeated or excessive use of sedatives, hypnotics, or anxiolytics without medical supervision. Psychological dependence on these medications for relief from anxiety, sleep issues, or other conditions. Lack of awareness about the potential for addiction or adverse effects of these drugs. Underlying mental health conditions that lead to self-medication with sedatives or hypnotics. Environmental and social factors such as stress, peer influence, or accessibility of these substances.
Key Symptoms: Hallucinations or false perceptions, which may be visual or auditory. Delusional thinking or beliefs that are not based in reality. Disorganized speech or erratic behavior. Confusion, disorientation, or impaired judgment. Physical symptoms such as dizziness, slurred speech, or unsteady gait. Mood swings, agitation, or increased anxiety. Possible loss of insight into the severity of their condition.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a thorough clinical assessment by a healthcare professional, including a detailed history of drug use and mental health symptoms. Medical tests may include blood tests or urine screenings to detect the presence of sedatives, hypnotics, or anxiolytics. Psychiatric evaluations can help determine the presence of a psychotic disorder. The clinician will also rule out other potential causes for psychosis, such as primary psychiatric illnesses or medical conditions.
Treatment Protocols: Treatment strategies are often multimodal and tailored to the individual's needs. They may include: - Medical detoxification under supervision to safely manage withdrawal symptoms. - Psychotherapy approaches such as cognitive-behavioral therapy (CBT) to address underlying issues and develop coping skills. - Medications to manage psychotic symptoms, if necessary, prescribed and monitored by a psychiatrist. - Support groups or counseling for substance abuse recovery. - Long-term monitoring and follow-up to prevent relapse and support mental health stability.
Clinical Advice & FAQs
Billing Guidance
Is F13.159 a billable ICD-10 code?
Yes, F13.159 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.159?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse with sedative, hypnotic or anxiolytic-induced psychotic disorder, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
